US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly ...

We want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

Health agencies working under Robert F. Kennedy Jr. are making changes to the nation's decades-old system for approving and ...

Companies focused on psychedelic medicines traded higher for the second straight session on Tuesday after FDA Commissioner ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

Kennedy Jr. has tasked the Food and Drug Administration with conducting a safety review of mifepristone, a pill used in most ...

In an interview on Friday, FDA Commissioner Marty Makary threw his weight behind psychedelic therapies, noting that patients ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...